XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Feb. 03, 2024
Jan. 28, 2023
Jan. 29, 2022
Cash flows from operating activities:      
Net income $ 27,854 $ 89,123 $ 56,713
Adjustments to reconcile net income to net cash provided by operating activities:      
Loss from retirement plan terminations 5,690    
Recognition of accumulated foreign currency translation adjustment   66  
Amortization and write-off of deferred debt issuance costs 77 76 1,179
Impairment (gain) of assets 116 (159) (2,344)
Depreciation and amortization 13,833 15,381 17,226
Gain on sale of equipment (107)    
Deferred taxes, net of valuation allowance 9,329 (31,624)  
Stock compensation expense 2,496 1,384 1,229
Board of directors' stock compensation 443 501 374
Changes in operating assets and liabilities:      
Accounts receivable (2,786) 390 4,306
Inventories 12,036 (11,240) 3,264
Prepaid expenses and other current assets (1,094) (599) (2,926)
Other assets 29 (80) 407
Accounts payable (10,195) 2,383 (1,926)
Operating leases, net (3,563) (7,510) (14,959)
Accrued expenses and other liabilities (4,564) 1,852 12,998
Net cash provided by operating activities 49,594 59,944 75,541
Cash flows from investing activities:      
Additions to property and equipment, net (17,418) (9,642) (5,272)
Proceeds from sale of equipment 145    
Purchase of short-term investments (79,883)    
Maturity of short-term investments 48,010    
Net cash used for investing activities (49,146) (9,642) (5,272)
Cash flows from financing activities:      
Repurchase of common stock (24,541) (12,728)  
Proceeds from issuance of common stock from private direct offering, net of offering costs     4,375
Proceeds from new FILO loan     17,500
Repayment of FILO loans     (32,500)
Borrowings under credit facility     40,297
Repayments under credit facility     (100,030)
Debt extinguishment costs     (1,111)
Debt issuance costs     (1,200)
Proceeds from the exercise of stock options 368 839 776
Tax withholdings paid related to net share settlements (759) (1,845) (1,867)
Net cash used for financing activities (24,932) (13,734) (73,760)
Net increase (decrease) in cash and cash equivalents (24,484) 36,568 (3,491)
Cash and cash equivalents:      
Beginning of period 52,074 15,506 18,997
End of period $ 27,590 $ 52,074 $ 15,506